熱門資訊> 正文
Tenaya Therapeutics宣布拟议公开募股
2025-12-12 05:16
- Tenaya Therapeutics (NASDAQ:TNYA) announced on Thursday that it intends to offer and sell units consisting of common stock and warrants to purchase shares of common stock.
- The company may also sell to certain investors, in lieu of units, pre-funded units consisting of pre-funded warrants to purchase shares of common stock at a purchase price of $0.001 per share and warrants to purchase shares of common stock.
- Leerink Partners and Piper Sandler are acting as joint bookrunning managers for the proposed offering.
- Shares -2.86%.
More on Tenaya Therapeutics
- Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform
- Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call - Slideshow
- Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript
- Tenaya Therapeutics GAAP EPS of -$0.12 beats by $0.03
- Tenaya Therapeutics falls after FDA clinical hold on heart disorder trial
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。